Scientific Reviews
Product Guides
Blogs
Topics
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!2025-02-06
8 Results for "
MEF2A
" in MedChemExpress (MCE) Product Catalog:
Products (8)
8 Results for "MEF2A" in MCE Product Catalog:
Cat. No.: HY-RS08309
Target:
Research Areas:
MEF2A Human Pre-designed siRNA Set A contains three designed siRNAs for MEF2A gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.
Cat. No.: HY-RS26209
Target:
Research Areas:
Mef2a Rat Pre-designed siRNA Set A contains three designed siRNAs for Mef2a gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.
Cat. No.: HY-174584
Target:
Research Areas:
Human MEF2A mRNA encodes the human myocyte enhancer factor 2A (MEF2A) protein, a DNA-binding transcription factor that activates many muscle-specific, growth factor-induced, and stress-induced genes. MEF2A is involved in several cellular processes, including muscle development, neuronal differentiation, cell growth control, and apoptosis.
Cat. No.: HY-RS19713
Target:
Research Areas:
Mef2a Mouse Pre-designed siRNA Set A contains three designed siRNAs for Mef2a gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.
Cat. No.: HY-P702970
Purity: ≥ 90%, as determined by reducing SDS-PAGE.
Synonyms: MEF2
Species:
Source:
-
-
Protocols
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!A suitable model is crucial in drug screening experiments. Organs can mimic the three-dimensional functional structure of internal organs, have similar spatial organization to corresponding organs, maintain some key characteristics, and reproduce some physiological functions. They are widely used for modeling and personalized drug screening physiological functions.2025-02-06
